Sudarshan Chemical Industries (SUDARSCHEM)₹1,054−0.12%Dyes And Pigments
In the Jun 2026 quarter (consolidated), Sudarshan Chemical Industries reported sales of ₹2,641 Cr, up 5.4% from Jun 2025, and net profit of ₹103 Cr, up 87.4% year on year. For the year to Mar 2026, sales were ₹9,783 Cr and net profit ₹40.90 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 601 | 565 | 763 | 634 | 695 | 665 | 1,348 | 2,506 | 2,383 | 2,100 | 2,789 | 2,641 |
| Expenses | 533 | 502 | 643 | 551 | 600 | 586 | 1,219 | 2,307 | 2,247 | 2,060 | 2,552 | 2,377 |
| Operating Profit | 66.12 | 62.05 | 119 | 81.08 | 94.16 | 79.07 | 127 | 192 | 132 | 38.08 | 227 | 259 |
| OPM % | 11.0% | 11.0% | 16.0% | 13.0% | 14.0% | 12.0% | 9.0% | 8.0% | 6.0% | 1.8% | 8.0% | 10.0% |
| Other Income | 6.01 | 4.01 | 3.01 | 4.01 | −6.01 | −26.02 | −38.08 | 33.03 | 38.05 | −24.05 | 32.05 | 32.03 |
| Interest | 10.01 | 9.01 | 8.01 | 7.01 | 9.01 | 11.01 | 21.01 | 44.01 | 44.05 | 36.04 | 41.01 | 40.01 |
| Depreciation | 35.08 | 35.08 | 36.11 | 36.09 | 37.07 | 37.08 | 57.14 | 99.19 | 97.29 | 101 | 50.15 | 93.16 |
| Profit before tax | 26.04 | 22.04 | 78.14 | 41.03 | 43.08 | 5.01 | 11.01 | 82.03 | 30.03 | −123 | 168 | 157 |
| Tax % | 32.0% | 34.0% | 26.0% | 28.0% | 30.0% | 89.0% | 97.0% | 33.0% | 35.0% | −6.0% | 51.0% | 34.0% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | −4.98 | −19.93 | −27.92 | 0.00 | 0.00 | −36.85 | 7.97 | 0.00 |
| Net Profit | 17.97 | 14.97 | 57.89 | 28.96 | 29.96 | 0.99 | 0.00 | 54.91 | 18.98 | −116 | 81.81 | 103 |
| EPS (Rs) | 2.57 | 2.10 | 8.37 | 4.24 | 4.31 | 0.06 | −0.51 | 6.00 | 1.48 | −14.64 | 10.00 | 12.21 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,399 | 1,280 | 1,328 | 1,590 | 1,706 | 1,863 | 2,198 | 2,300 | 2,536 | 3,343 | 9,783 | 9,913 |
| Expenses | 1,229 | 1,090 | 1,136 | 1,383 | 1,457 | 1,569 | 1,917 | 2,082 | 2,212 | 2,955 | 9,150 | 9,236 |
| Operating Profit | 170 | 189 | 191 | 207 | 248 | 290 | 278 | 213 | 319 | 383 | 604 | 657 |
| OPM % | 12.0% | 15.0% | 14.0% | 13.0% | 15.0% | 16.0% | 13.0% | 9.0% | 13.0% | 11.0% | 6.0% | 6.6% |
| Other Income | 14.02 | 25.03 | 15.02 | 81.10 | 22.05 | 7.01 | 5.01 | 5.01 | 333 | −67.13 | 75.11 | 78.08 |
| Interest | 37.03 | 30.02 | 25.01 | 19.02 | 15.99 | 20.02 | 23.01 | 44.04 | 39.01 | 51.03 | 174 | 161 |
| Depreciation | 48.09 | 49.14 | 58.10 | 66.14 | 74.22 | 87.22 | 89.21 | 114 | 141 | 166 | 348 | 342 |
| Profit before tax | 99.08 | 136 | 123 | 203 | 180 | 190 | 171 | 60.09 | 472 | 99.11 | 157 | 232 |
| Tax % | 29.0% | 25.0% | 31.0% | 33.0% | 20.0% | 26.0% | 24.0% | 25.0% | 24.0% | 39.0% | 74.0% | — |
| Exceptional items | 0.00 | −1.99 | −0.99 | 54.84 | 13.95 | 0.00 | 0.00 | 0.00 | 245 | −15.95 | 6.97 | −28.88 |
| Net Profit | 69.88 | 101 | 84.80 | 135 | 145 | 141 | 130 | 44.93 | 356 | 59.89 | 40.90 | 87.97 |
| EPS (Rs) | 10.08 | 14.61 | 12.23 | 19.50 | 20.86 | 20.35 | 18.75 | 6.46 | 51.57 | 7.10 | 2.83 | 9.05 |
| Dividend payout % | 30.0% | 23.9% | 29.0% | 30.9% | 30.0% | 28.9% | 26.9% | 22.9% | 8.9% | 62.9% | 175.9% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 14.01 | 14.01 | 14.02 | 14.03 | 14.02 | 14.02 | 14.02 | 14.01 | 14.03 | 14.03 | 16.04 | 16.03 |
| Reserves | 249 | 300 | 367 | 426 | 554 | 587 | 731 | 819 | 814 | 1,136 | 3,378 | 3,437 |
| Borrowings | 433 | 431 | 434 | 431 | 367 | 502 | 618 | 823 | 830 | 467 | 2,380 | 2,476 |
| Other Liabilities | 318 | 346 | 379 | 433 | 425 | 522 | 638 | 706 | 724 | 729 | 3,871 | 3,637 |
| Total Liabilities | 1,013 | 1,091 | 1,193 | 1,305 | 1,359 | 1,624 | 2,001 | 2,362 | 2,383 | 2,346 | 9,643 | 9,568 |
| Fixed Assets | 332 | 357 | 450 | 474 | 464 | 625 | 613 | 829 | 1,122 | 1,099 | 2,764 | 2,978 |
| CWIP | 7.99 | 14.99 | 7.99 | 5.99 | 24.01 | 48.01 | 278 | 285 | 43.98 | 15.01 | 121 | 144 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 | 1.01 | 2.01 | 2.01 | 2.01 | 546 | 567 |
| Other Assets | 673 | 718 | 735 | 824 | 872 | 950 | 1,108 | 1,247 | 1,214 | 1,230 | 6,212 | 5,877 |
| Inventories | 250 | 253 | 260 | 272 | 307 | 410 | 411 | 565 | 493 | 437 | 2,497 | 2,441 |
| Trade receivables | 316 | 352 | 343 | 333 | 346 | 363 | 484 | 500 | 485 | 585 | 1,223 | 1,677 |
| Cash & equivalents | 22.93 | 24.91 | 14.95 | 13.94 | 7.97 | 15.94 | 23.93 | 34.88 | 28.91 | 55.77 | 1,506 | 1,071 |
| Total Assets | 1,013 | 1,091 | 1,193 | 1,305 | 1,359 | 1,624 | 2,001 | 2,362 | 2,383 | 2,346 | 9,643 | 9,568 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 112 | 164 | 163 | 148 | 71.03 | 263 | 165 | 178 | 287 | 193 | 71.01 | 344 |
| Cash from investing activity | −61.20 | −83.23 | −136 | −87.24 | −27.07 | −221 | −267 | −308 | −190 | 280 | −1,615 | 166 |
| Cash from financing activity | −42.94 | −80.95 | −37.94 | −61.90 | −47.94 | −38.92 | 108 | 138 | −103 | −445 | 2,591 | −680 |
| Net cash flow | 8.02 | 0.00 | −10.02 | −2.01 | −3.01 | 3.01 | 8.02 | 9.02 | −5.01 | 27.08 | 1,060 | −171 |
| Capex | 57.23 | 85.28 | 137 | 87.23 | 102 | 256 | 271 | 311 | 193 | 78.23 | 106 | 285 |
| Free cash flow | 56.19 | 79.30 | 29.10 | 61.25 | −31.09 | 9.03 | −103 | −131 | 96.37 | 462 | −33.12 | 63.18 |
| CFO / OP % | 97.0% | 108.9% | 102.9% | 92.0% | 49.9% | 131.0% | 70.0% | 77.9% | 140.0% | 86.9% | 40.0% | 90.9% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 96 | 92 | 98 | 92 | 79 | 78 | 95 | 83 | 77 | 84 | 134 | 63 |
| Inventory days | 125 | 113 | 134 | 131 | 119 | 154 | 142 | 163 | 132 | 113 | 515 | 179 |
| Days payable | 93 | 95 | 138 | 125 | 93 | 138 | 151 | 149 | 135 | 131 | 286 | 112 |
| Cash conversion cycle | 127 | 109 | 93 | 96 | 105 | 92 | 85 | 96 | 73 | 65 | 362 | 129 |
| Working capital days | 26 | 40 | 14 | 43 | 51 | 24 | 29 | 18 | 23 | 40 | 173 | 62 |
| ROCE % | 16.1% | 19.0% | 22.0% | 18.0% | 17.0% | 18.0% | 17.1% | 13.0% | 6.0% | 11.0% | 6.0% | 5.0% |
For the Jun 2026 quarter, Sudarshan Chemical Industries reported sales of ₹2,641 Cr, up 5.4% year on year and net profit of ₹103 Cr, up 87.4% year on year. The operating margin was 10.0%.
Sudarshan Chemical Industries' sales for the year to Mar 2026 were ₹9,783 Cr; over the last twelve months they were ₹9,913 Cr.
Net profit for the year to Mar 2026 was ₹40.90 Cr, and ₹87.97 Cr over the last twelve months. Earnings per share over the same trailing period were ₹9.05.
Sudarshan Chemical Industries reported borrowings of ₹2,476 Cr at Mar 2026, against cash and equivalents of ₹1,071 Cr.
Cash from operations was ₹344 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹63.18 Cr.